TrialEuropean heart journal2020

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.

Lars Wallentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.